Illumina to pay $9.8M to resolve alleged cyber faults

U.S. biotechnology firm Illumina has agreed to settle alleged violations of the False Claims Act stemming from the sale of vulnerable genomic sequencing systems to the government with a $9.8 million fee, reports The Record, a news site by cybersecurity firm Recorded Future.SCM feed for Endpoint/Device SecurityRead More